Finanical Reports

Explore the landscape of Finanical Reports in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finanical Reports to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Regeneron Extends BARDA Agreement With $270 Million Inmazeb Supply Deal for U.S. Ebola Preparedness Through 2031
CompanyDeals

Regeneron Extends BARDA Agreement With $270 Million Inmazeb Supply Deal for U.S. Ebola Preparedness Through 2031

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced that it has extended its agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response…

Astellas' Non-Hormonal VEOZA Gains NMPA NDA Acceptance for Menopausal Hot Flashes in China

Astellas’ Non-Hormonal VEOZA Gains NMPA NDA Acceptance for Menopausal Hot Flashes in China

Sino Biopharmaceutical's CTTQ Earns Dual CDE Breakthrough Therapy Designations for TQ-A3334 and TQA3605 in Chronic Hepatitis B

Sino Biopharmaceutical’s CTTQ Earns Dual CDE Breakthrough Therapy Designations for TQ-A3334 and TQA3605 in Chronic Hepatitis B

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

SciClone Pharmaceuticals Reports 10.8% Revenue Growth in 2022 Interim Results

Company

YiChang HEC Reports Strong Recovery in 2022 Interim Results

Company

Sino Biopharmaceutical Reports Mixed Results in 2022 Interim Report

Company

China Resources Pharma Reports Strong Interim Results Amid COVID-19

Company

Sihuan Pharmaceutical Reports Decline in Revenues Amid COVID-19 Lockdowns

Company

Lee’s Pharmaceutical Reports H1 Revenue Growth Amid Product Portfolio Shift

Company

China Pharma H1 2022 Financials: 40% of Firms Report Revenue and Profit Growth

Company

GenScript Biotech’s H1 2022 Revenue Rises 32.7% on Carvykti CAR-T Sales

Show More